EP Plenary session Joint debate - Impact of the Covid-19 crisis on the aviation

EP Plenary session - State of play of the implementation of the EU Digital Covid Certificate regulations

Zaventem Airport - Departures board

Press conference by David SASSOLI, EP President on the ' Situation on Coronavirus '.

EP Press conference on ' The EU response to the Coronavirus '

The European Centre for Disease Prevention and Control (ECDC)

Covid-19 pandemic: Taïwan donations to Europe

A shipment of donations of aid from Taiwan to combat Covid-19 arrives by airplane from Taipeh to Luxemburg airport on April 9, 2020. The shipment includes masks with destination Italy and Spain, as well as bilateral donations to other Member States.

Remote participation of MEP DANIELSON to the Extraordinary Plenary session of 16 and 17 April 2020.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Welcome and opening remarks by Pascal CANFIN (Renew,FR), ENVI Chair and by Cristian-Silviu BUŞOI (EPP,RO), ITRE Chair. This transcription speech is the result of an automatic process. Check against delivery.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Welcome and opening remarks by the Chairs

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Presentation by the speakers. This transcription speech is the result of an automatic process. Check against delivery.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Presentation by the speakers.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Conclusion and closing remarks by Pascal CANFIN (Renew, FR), ENVI Chair and by Cristian-Silviu BUŞOI (EPP, RO), ITRE Chair.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Conclusion and closing remarks by the Chairs

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 1 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 1/2 Q&A with ENVI and ITRE Members.

MEPS from the Committee on the Environment, Public Health and Food Safety (ENVI) and from the Committee on Industry, Research and Energy (ITRE) hold a public hearing with researchers and representatives from pharmaceutical companies and civil society organisations on how to secure access to COVID-19 vaccines for all, including challenges linked to clinical trials, production and distribution in the European Parliament in Brussels.

How to secure access to COVID-19 vaccines for EU citizens; clinical trials, production and distribution challenges: extracts from the joint public hearing

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 2 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 2/ 2 Q&A with ENVI and ITRE Members.

Ursula von der LEYEN, President of the EC gives her first State of the European Union address during the plenary session (14-17 September) of the European Parliament in Brussels. She is set to outline the impact of the COVID-19 outbreak, on the recovery plan and the economic situation, on the Green Deal, on the migration crisis, on the EU-Turkey relations, on the on the situation in Belarus,...

State of the European Union 2020: extracts from the statement by Ursula von der LEYEN, President of the EC

During the plenary session (14-17 September 2020) of the European Parliament in Brussels, MEPs accelerate the procedure that will enable the EU to borrow €750 billion for the “Next Generation EU” recovery plan. The vote on the own resources decision makes it possible to start the ratification process in 27 EU countries - so that the COVID-19 recovery plan can be launched as soon as possible.

Proposal for a Council decision on the system of own resources of the European Union: extracts from the debate (14/09) from the vote and from the press conference

Ursula von der LEYEN, President of the EC gives her first State of the European Union address during the plenary session (14-17 September) of the European Parliament in Brussels. She is set to outline the impact of the Commission’s work in mitigating the COVID-19 health and economic crisis, and to present her vision for economic recovery, the fight against climate change, and the situation in Europe’s neighbourhood. Political group leaders will react to her speech, assess the Commission’s work and set out their views on the 2021 priorities.

State of the European Union 2020: extracts of the debate on COVID 19 European Common Response

Valérie HAYER (RE, FR) and José Manuel FERNANDES (EPP, PT), rapporteurs, speak to the press on the legislative opinion on the Own Resources decision, in the European Parliament n Brusels.

Press conference by Valérie HAYER (RE, FR) and José Manuel FERNANDES (EPP, PT), rapporteurs, on the legislative opinion on the Own Resources decision

During the plenary session (14-17 September 2020) in the European Parliament in Brussels, Ursula VON DER LEYEN delivers the State of the European Union (SOTEU 2020) before the MEPs. In the first part of her speech, VON DER LEYEN focused on the first phases of the crisis caused by the Covid19 pandemic and how European institutions reacted to it. The creation of green lines for medical goods between member states, the increased production of masks gloves and ventilators and the return of 600 thousand European citizens to their homes. Finally, the proposal to build a stronger European Health Union. This transcription speech is the result of an automatic process. Check against delivery.

Part 1/5 - State of the European Union debate: Opening statement by Ursula VON DER LEYEN, President of the European Commission (on Covid-19 pandemic)

During the plenary session (14-17 September 2020) in the European Parliament in Brussels, Ursula VON DER LEYEN delivers the State of the European Union (SOTEU 2020) before the MEPs. In the second part of her speech VON DER LEYEN focused on the next actions the Commission will take on healthcare, labour market and a capital markets union. On the table there is the reinforcement and empowerment the European Medicines Agency, and the institution of BARDA, a new agency for biomedical advanced research and development. Lastly, the proposal of a minimum wages mechanism, either through collective bargaining or through statutory minimum wages. This transcription speech is the result of an automatic process. Check against delivery.

Part 2/5 - State of the European Union debate: Opening statement by Ursula VON DER LEYEN, President of the European Commission (Health and Social policy)

During the plenary session (14-17 September 2020) in Brussels, MEPs debate on the Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market. Opening statements.

Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market: Opening statements of the Council and Commission

During the plenary session (14-17 September 2020) in Brussels, MEPs debate on the Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market. First round of political group leaders.

Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market: First round of political group leaders

During the plenary session (14-17 September 2020) in Brussels, MEPs debate on the Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market. MEPs debate

Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market: MEPs debate

During the plenary session (14-17 September 2020) in Brussels, MEPs debate on the Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market. Closing statements

Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market: Closing statements

Statements by European Parliament’s political groups leaders at the debate "Toghether for a better Europe". This event is taking place on the eve of one of the most important moments for the European Institutions : the State of the Union debate.

562 rezultatov